Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Piperonal. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.79 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.79 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.51 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.49 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.49 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.49 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.49 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.49 |
| ▸ | CRHBP | P24387 | 1/20 | 0.49 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Piperonal SCHEMBL1774149 | 0.91 | ALDH1A1 (0.82) | ALDH1A1HSD17B10TDP1TRPM8CYP3A4 | |
| Piperonal SCHEMBL6905345 | 0.89 | ALDH1A1 (0.68) | ALDH1A1HSD17B10TDP1TRPM8CYP3A4 | |
| Piperonal SCHEMBL29318 | 0.89 | ALDH1A1 (1.00) | ALDH1A1HSD17B10TDP1CYP3A4ATM | |
| Piperonal SCHEMBL1864802 | 0.89 | ALDH1A1 (1.00) | ALDH1A1HSD17B10TDP1CYP3A4ATM | |
| Piperonal SCHEMBL29411164 | 0.89 | ALDH1A1 (1.00) | ALDH1A1HSD17B10TDP1CYP3A4ATM | |
| Piperonal SCHEMBL16161395 | 0.88 | ALDH1A1 (0.82) | ALDH1A1HSD17B10TDP1TRPM8CYP3A4 | |
| Piperonal SCHEMBL5958791 | 0.87 | ALDH1A1 (0.96) | ALDH1A1HSD17B10TDP1CYP3A4ATM | |
| Piperonal SCHEMBL28017062 | 0.87 | ALDH1A1 (0.96) | ALDH1A1HSD17B10TDP1CYP3A4ATM | |
| Piperonal SCHEMBL4204261 | 0.86 | ALDH1A1 (0.79) | ALDH1A1HSD17B10TDP1TRPM8CYP3A4 | |
| Piperonal SCHEMBL28534378 | 0.86 | ALDH1A1 (0.85) | ALDH1A1HSD17B10TDP1CYP3A4ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115996686-B | Medical device comprising expandable muscle polymer | 巴德外周血管股份有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-110869487-B | Metabolic engineering for microbial production of terpenoid products | 马努斯生物合成股份有限公司 | 2024-01-02 | — | — | CN | disclosed |
| CN-115996686-A | Medical device comprising expandable muscle polymer | 巴德外周血管股份有限公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-113474390-A | Polyurethane for cosmetic and method for producing polyurethane for cosmetic | 株式会社ADEKA | 2021-10-01 | — | — | CN | disclosed |
| CN-209210679-U | A kind of piperonal recyclable device | 四川惠泉生物科技有限公司 | 2019-08-06 | — | — | CN | disclosed |
| US-7138530-B2 | Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2006-11-21 | — | — | US | disclosed |
| US-7109354-B2 | Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2006-09-19 | — | — | US | disclosed |
| EP-1549632-A4 | NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS | DIMENSIONAL PHARM INC (US) | 2005-11-09 | — | — | EP | disclosed |
| US-20050234081-A1 | Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions | SUBASINGHE NALIN | 2005-10-20 | — | — | US | disclosed |
| EP-1549632-A1 | NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2005-07-06 | — | — | EP | disclosed |
| US-20040009995-A1 | Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2004-01-15 | — | — | US | disclosed |
| WO-2003099805-A1 | NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2003-12-04 | — | — | WO | disclosed |
| US-4503033-A | SHAMPOO, LOTIONS, HAIR SPRAYS | SOCIETE ANONYME DITE: L'OREAL (FR) | 1985-03-05 | — | — | US | disclosed |
| US-4348383-A | Dithioether-based cosmetic compositions for the treatment of the oily state of hair and skin | L'OREAL (FR) | 1982-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234081-A1 | Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions | C5, C9, C1R | ALDH1A1 3674/4885HSD17B10 3904/4885TDP1 4176/4885 |
| US-20040009995-A1 | Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions | C5, C9, C1R | ALDH1A1 2779/4885HSD17B10 3220/4885TDP1 3250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.